GDF10 and Hepatic fibrosis: Notably, AAV-Gdf10 treatment in HFFC diet-fed mice resulted in reduced serum AST and ALT levels, accompanied by significant improvements in hepatic fibrosis as demonstrated by H&E, Sirius Red, and Masson staining (Fig. 2B, C).